Reports: ZORA Program (Slovenia): Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
Go back to [[Slovenia]] page | Go back to [[Slovenia]] page | ||
''' | '''Primary purpose:''' To actively screen and reduce morbidity and mortality from cervical cancer in Slovenia, aiming for at least 70% coverage of women aged 20-64 through regular cervical smear examinations every three years. | ||
''' | '''Sponsor, manager or home institution:''' [[dataOwner::Ljubljana Oncology Institute]]; [[dataOwner::ZORA Program]]. | ||
'''Type of information:''' The percentage of women in the target group who are screened according to the program guidelines (screening); The number of new patients in a given year; (RMV incidence rate); Mortality due to RMV; The ratio between the number of newly detected precancerous and cancerous changes per year. [https://zora.onko-i.si/publikacije/letna-porocila Click here to learn more]. | |||
''' | '''Data level:''' [[dataLevel::national level]]. | ||
''' | '''Cancer areas of interest:''' [[hasCancerType::C51-C58: Female genitalia cancer]]. [https://zora.onko-i.si/program-zora/namen-in-cilji Click here to learn more]. | ||
'''Access to information:''' | '''Access to information:''' [https://zora.onko-i.si/publikacije/letna-porocila Click here to access]. | ||
Revision as of 17:08, 24 May 2024
Go back to Slovenia page
Primary purpose: To actively screen and reduce morbidity and mortality from cervical cancer in Slovenia, aiming for at least 70% coverage of women aged 20-64 through regular cervical smear examinations every three years.
Sponsor, manager or home institution: Ljubljana Oncology Institute; ZORA Program.
Type of information: The percentage of women in the target group who are screened according to the program guidelines (screening); The number of new patients in a given year; (RMV incidence rate); Mortality due to RMV; The ratio between the number of newly detected precancerous and cancerous changes per year. Click here to learn more.
Data level: national level.
Cancer areas of interest: C51-C58: Female genitalia cancer. Click here to learn more.
Access to information: Click here to access.
